KR20210148195A - 질용 정제 제제 - Google Patents
질용 정제 제제 Download PDFInfo
- Publication number
- KR20210148195A KR20210148195A KR1020217033774A KR20217033774A KR20210148195A KR 20210148195 A KR20210148195 A KR 20210148195A KR 1020217033774 A KR1020217033774 A KR 1020217033774A KR 20217033774 A KR20217033774 A KR 20217033774A KR 20210148195 A KR20210148195 A KR 20210148195A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- gdl
- hpmc
- nag
- range
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19167495 | 2019-04-05 | ||
| EP19167495.1 | 2019-04-05 | ||
| PCT/EP2020/059582 WO2020201515A1 (en) | 2019-04-05 | 2020-04-03 | Vaginal tablet formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20210148195A true KR20210148195A (ko) | 2021-12-07 |
Family
ID=66101895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217033774A KR20210148195A (ko) | 2019-04-05 | 2020-04-03 | 질용 정제 제제 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20220193031A1 (zh) |
| EP (1) | EP3976000B1 (zh) |
| JP (1) | JP2022537478A (zh) |
| KR (1) | KR20210148195A (zh) |
| CN (1) | CN113660928B (zh) |
| AR (1) | AR118580A1 (zh) |
| AU (1) | AU2020252268A1 (zh) |
| BR (1) | BR112021019999A2 (zh) |
| CA (1) | CA3134086A1 (zh) |
| CL (1) | CL2021002430A1 (zh) |
| CO (1) | CO2021014253A2 (zh) |
| EA (1) | EA202192716A1 (zh) |
| ES (1) | ES2961736T3 (zh) |
| HU (1) | HUE062772T2 (zh) |
| IL (1) | IL286942A (zh) |
| MA (1) | MA56011A (zh) |
| MX (1) | MX2021012146A (zh) |
| PE (1) | PE20220381A1 (zh) |
| PL (1) | PL3976000T3 (zh) |
| SG (1) | SG11202110236QA (zh) |
| TW (1) | TW202103693A (zh) |
| UA (1) | UA127823C2 (zh) |
| WO (1) | WO2020201515A1 (zh) |
| ZA (1) | ZA202106877B (zh) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Vesely Renata Maria Cavaliere | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
| US6287599B1 (en) * | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| US20030017207A1 (en) * | 2001-05-01 | 2003-01-23 | Lin Shun Y. | Compositions and methods for treating vulvovaginitis and vaginosis |
| ITBO20110461A1 (it) * | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| WO2017174731A1 (en) * | 2016-04-06 | 2017-10-12 | Gedea Biotech Ab | Glucono delta-lactone for treatment of vaginal fungal infections |
| MX2020003660A (es) | 2017-10-06 | 2020-08-03 | Gedea Biotech Ab | Derivados de acido gluconico para ser usados en el tratamiento y/o prevencion de infecciones microbianas. |
-
2020
- 2020-04-03 CN CN202080027260.1A patent/CN113660928B/zh active Active
- 2020-04-03 US US17/601,521 patent/US20220193031A1/en active Pending
- 2020-04-03 EA EA202192716A patent/EA202192716A1/ru unknown
- 2020-04-03 UA UAA202106160A patent/UA127823C2/uk unknown
- 2020-04-03 CA CA3134086A patent/CA3134086A1/en active Pending
- 2020-04-03 KR KR1020217033774A patent/KR20210148195A/ko active Search and Examination
- 2020-04-03 MA MA056011A patent/MA56011A/fr unknown
- 2020-04-03 SG SG11202110236QA patent/SG11202110236QA/en unknown
- 2020-04-03 JP JP2021560220A patent/JP2022537478A/ja active Pending
- 2020-04-03 AU AU2020252268A patent/AU2020252268A1/en active Pending
- 2020-04-03 WO PCT/EP2020/059582 patent/WO2020201515A1/en unknown
- 2020-04-03 HU HUE20715885A patent/HUE062772T2/hu unknown
- 2020-04-03 AR ARP200100936A patent/AR118580A1/es unknown
- 2020-04-03 PE PE2021001545A patent/PE20220381A1/es unknown
- 2020-04-03 PL PL20715885.8T patent/PL3976000T3/pl unknown
- 2020-04-03 ES ES20715885T patent/ES2961736T3/es active Active
- 2020-04-03 MX MX2021012146A patent/MX2021012146A/es unknown
- 2020-04-03 BR BR112021019999A patent/BR112021019999A2/pt unknown
- 2020-04-03 EP EP20715885.8A patent/EP3976000B1/en active Active
- 2020-04-06 TW TW109111529A patent/TW202103693A/zh unknown
-
2021
- 2021-09-17 ZA ZA2021/06877A patent/ZA202106877B/en unknown
- 2021-09-20 CL CL2021002430A patent/CL2021002430A1/es unknown
- 2021-10-04 IL IL286942A patent/IL286942A/en unknown
- 2021-10-25 CO CONC2021/0014253A patent/CO2021014253A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11202110236QA (en) | 2021-10-28 |
| WO2020201515A1 (en) | 2020-10-08 |
| JP2022537478A (ja) | 2022-08-26 |
| CN113660928A (zh) | 2021-11-16 |
| PL3976000T3 (pl) | 2023-12-04 |
| ZA202106877B (en) | 2023-03-29 |
| AR118580A1 (es) | 2021-10-20 |
| CO2021014253A2 (es) | 2021-11-19 |
| EA202192716A1 (ru) | 2022-01-17 |
| IL286942A (en) | 2021-12-01 |
| HUE062772T2 (hu) | 2023-12-28 |
| BR112021019999A2 (pt) | 2021-12-07 |
| CA3134086A1 (en) | 2020-10-08 |
| EP3976000A1 (en) | 2022-04-06 |
| TW202103693A (zh) | 2021-02-01 |
| MA56011A (fr) | 2022-04-06 |
| CL2021002430A1 (es) | 2022-07-01 |
| EP3976000C0 (en) | 2023-08-02 |
| AU2020252268A1 (en) | 2021-10-21 |
| ES2961736T3 (es) | 2024-03-13 |
| MX2021012146A (es) | 2021-12-10 |
| US20220193031A1 (en) | 2022-06-23 |
| UA127823C2 (uk) | 2024-01-10 |
| PE20220381A1 (es) | 2022-03-18 |
| EP3976000B1 (en) | 2023-08-02 |
| CN113660928B (zh) | 2024-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Permana et al. | Bioadhesive-thermosensitive in situ vaginal gel of the gel flake-solid dispersion of itraconazole for enhanced antifungal activity in the treatment of vaginal candidiasis | |
| JP6429131B2 (ja) | 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用 | |
| PL202918B1 (pl) | Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie | |
| KR20100016060A (ko) | 부인과 질환의 치료에서의 락트산 올리고머의 용도 | |
| CA3113462A1 (en) | Formulations for treatment of dry eye disease | |
| US20050255157A1 (en) | Sustained release, mucoadhesive vaginal pharmaceutical compositions | |
| EA031959B1 (ru) | Фармацевтические композиции с гидратирующим и смазывающим действием | |
| JP2007077152A (ja) | 膣のｐＨを低下させるための組成物および方法 | |
| ES2652251T3 (es) | Composiciones farmacéuticas que contienen ácido láctico oligomérico | |
| CN102698277A (zh) | 缓释释药的药物载体 | |
| EP3501507B1 (en) | Macrogols for application to the mucosa, and therapeutic uses thereof | |
| KR20210148195A (ko) | 질용 정제 제제 | |
| EP2643003B1 (en) | Vaginal composition based on alkyl polyglucosides | |
| WO2010026469A1 (es) | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual | |
| MXPA05013798A (es) | Composiciones farmaceuticas que comprenden acido ascorbico para el tratamiento de super infecciones fungales y recurrencias fungales. | |
| CN104873496A (zh) | 双唑泰阴道泡腾片及其制备方法 | |
| EP4324465A1 (en) | Compounds for use in the treatment of a microbial infection in the urogenital system | |
| DE102010032590B4 (de) | Arzneimittel zur lokalen Behandlung der Wundinfektion | |
| Samy et al. | Design, in vitro and in vivo evaluation of Fluconazole Bioadhesive Vaginal tablets | |
| Noutchang | Design and evaluation of fast dispersible tablets of lamivudine using selected natural superdisintegrants | |
| Kumar | AN OVERVIEW OF EXCIPIENTS USED IN SEMISOLID PREPARATION | |
| Siddeswar | Formulation and Evaluation of Fluconazole Muco-Adhesive Vaginal Tablets | |
| KR100797557B1 (ko) | 생식기 염증 예방 또는 치료용 약제학적 조성물 | |
| BR102019004426A2 (pt) | Creme vaginal antifúngico contendo curcumina | |
| CN110913850A (zh) | 含有帕马考昔和曲马多的用于治疗急性和慢性疼痛的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination |